Home

IPBS

Toulouse

Better understanding towards better therapeutics in Cancer, Infection and Inflammation.

Agenda

Featured publications (2022-2023)

Seif-El-Dahan*, Kefala-Stavridi*, Frit*, Hardwick* et al. (2023) PAXX binding to the NHEJ machinery explains functional redundancy with XLF. Sci Adv 9(22): eadg2834

Mosquera-Restrepo et al. (2022) A M. tuberculosis fingerprint in human breath allows tuberculosis detection. Nat Commun 13: 7751

Planès*, Pinilla*, Santoni*, Hessel*, Passemar* et al. (2022) Human NLRP1 is a sensor of pathogenic coronavirus 3CL proteases in lung epithelial cells. Mol Cell 82: 2385-2400.e9

Asrir*, Tardiveau*, Coudert*, Laffont*, Blanchard* et al. (2022) Tumor-associated high endothelial venules mediate lymphocyte entry into tumors and predict response to PD-1 plus CTLA-4 combination immunotherapy. Cancer Cell 40: 318-334.e9

Kefala-Stavridi*, Gontier*, Morin*, Frit* et al. (2023) Structural and functional basis of inositol hexaphosphate stimulation of NHEJ through stabilization of Ku-XLF interaction. Nucleic Acids Res Oct 23:gkad863

About

the IPBS

The IPBS is a joint research center of the CNRS and the University of Toulouse. Occupying 12,000 m2 in the heart of the main campus of the University of Toulouse III-Paul Sabatier, which offers high-level multidisciplinary training in the fields of science, health and engineering, the IPBS is part of one of the most important scientific research poles in health and biological sciences in France.

0
Staff
0
Research teams
0
CNRS International Actions
0
running
European grants
0
Nationalities
0
M2 of laboratories
You wish to work on cancer, infectious or inflammatory diseases, with cutting-edge approaches in cellular, molecular and structural biology, in a rich and stimulating environment?
Join us!

READY TO COLLABORATE ?

Get In Touch